Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Clinical Cardiology|August 25, 2016
Percutaneous Coronary Intervention for Bifurcation: How Can We Outperform the Provisional Strategy?Andrew Kei-Yan Ng, Man-Hong Jim
Frontiers in Cardiovascular Medicine|November 15, 2021
High-Intensity Statin vs. Low-Density Lipoprotein Cholesterol Target for Patients Undergoing Percutaneous Coronary Intervention: Insights From a Territory-Wide Cohort Study in Hong KongAndrew Kei-Yan Ng, Pauline Yeung Ng, April Ip, et al.
Critical Care (London, England)|May 15, 2016
Speckle tracking echocardiography in patients with septic shock: a case control study (SPECKSS)Pauline Yeung Ng, Wai Ching Sin, Andrew Kei-Yan Ng, et al.
Cardiovascular Intervention and Therapeutics|January 2, 2021
Factors associated with long-term major adverse cardiac events of coronary bioresorbable vascular scaffoldAndrew Kei-Yan Ng, Pauline Yeung Ng, Chung-Wah Siu, et al.
The Journal of Invasive Cardiology|June 2, 2021
Comparison Between Bare-Metal Stents, First-Generation Drug-Eluting Stents, and Bioresorbable Vascular ScaffoldsAndrew Kei-Yan Ng, Pauline Yeung Ng, Chung-Wah Siu, et al.
Open Heart|January 12, 2022
Trade-off of major bleeding versus myocardial infarction on mortality after percutaneous coronary interventionAndrew Kei-Yan Ng, Pauline Yeung Ng, April Ip, et al.
Frontiers in Cardiovascular Medicine|March 14, 2022
Survivals of Angiography-Guided Percutaneous Coronary Intervention and Proportion of Intracoronary Imaging at Population Level: The Imaging ParadoxAndrew Kei-Yan Ng, Pauline Yeung Ng, April Ip, et al.
Stroke and Vascular Neurology|March 10, 2022
Risk of ischaemic and haemorrhagic stroke in Chinese undergoing percutaneous coronary intervention treated with potent P2Y12 inhibitor versus clopidogrelAndrew Kei-Yan Ng, Pauline Yeung Ng, April Ip, et al.
BMJ Open Gastroenterology|August 12, 2021
Association between proton pump inhibitors after percutaneous coronary intervention and risk of gastric cancerAndrew Kei-Yan Ng, Pauline Yeung Ng, April Ip, et al.
Journal of the American Heart Association|December 24, 2024
Atherothrombotic Outcomes After Sodium-Glucose Cotransporter 2 Inhibitors Versus Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 Diabetes: A Territory-Wide Retrospective Cohort StudyPauline Yeung Ng, Andrew Kei-Yan Ng, April Ip, et al.
Pageof 3